A carregar...
The development of neutralizing antibodies against SARS-CoV-2 and their common features
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide severe coronavirus disease 2019 (COVID-19) pandemic since December 2019. There is a great demand for effective therapies for the prevention and treatment of COVID-19. Developing therapeutic neutralizing antibodies (N...
Na minha lista:
| Publicado no: | J Mol Cell Biol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799018/ https://ncbi.nlm.nih.gov/pubmed/33377928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjaa070 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|